Immunogenicity of an <i>Escherichia coli</i>-Produced Recombinant 9-Valent Human Papillomavirus Vaccine in Mice and Rats

<b>Background:</b> Prophylactic human papillomavirus (HPV) vaccines are crucial for preventing HPV-related cancers. This study aimed to preclinically evaluate a novel recombinant 9-valent HPV vaccine produced in <i>Escherichia coli</i> (<i>E. coli</i>), which targets HPV types 6, 11, 16, 18, 31, 33,...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yu-Ying Liu, Fei Yin, Wen-Juan Li, Dan Chen, Shu-Ming Wu, Xiao Chen, Yan Wang, Zeng-Min Yang, Hai-Jiang Zhang, Yong-Jiang Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2026-05-01
Colección:	Vaccines
Materias:	human papillomavirus vaccine immunogenicity immune persistence <i>Escherichia coli</i>
Acceso en línea:	https://www.mdpi.com/2076-393X/14/5/407
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!